top of page
PeriphaGen's lead product, PGN-503, is designed to prevent or treat peripheral neuropathy in patients receiving chemotherapy, but that's just the start of what we can do.
SEE WHAT PERIPHAGEN HAS TO OFFER
PeriphaGen’s NET vector technology allows for targeted delivery to specific sensory nerves via a simple intradermal skin injection, thus our lead products have focused on treating peripheral nerve disorders such as neuropathy and chronic pain. However, the unique capabilities of our vector platform can be exploited to address a variety therapeutic areas and uses.
NET Platform for Neuropathy - PGN-503
Joint-Deleted Vectors for Large Payloads and Genetic Engineering
HSV-1 Manufacturing Services
bottom of page